Vera Therapeutics Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

23.70

0.33 (1.41%)

At close: May 01, 2025, 3:59 PM

23.75

0.21%

Pre-market: May 02, 2025, 04:31 AM EDT

Vera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-152.15M	-95.99M	-89.06M	-32.61M	-53.41M	-11.85M
Depreciation & Amortization	105K	-4.09M	-846K	176K	251K	509K
Stock-Based Compensation	20.8M	11.49M	8.89M	3.01M	331K	263K
Other Working Capital	6.11M	-5M	-3.86M	3.04M	-444K	807K
Other Non-Cash Items	-6.1M	2.27M	6.67M	4M	16.71M	173K
Deferred Income Tax	n/a	n/a	n/a	-1.8M	1.19M	104K
Change in Working Capital	2.66M	-5.87M	6.75M	3.51M	123K	516K
Operating Cash Flow	-134.68M	-92.18M	-67.6M	-23.71M	-34.81M	-10.29M
Capital Expenditures	-972K	-63K	-62K	n/a	-99K	-125K
Cash Acquisitions	n/a	n/a	70.49K	796K	57K	n/a
Purchase of Investments	-711.99M	-224.93M	-148.49M	n/a	n/a	n/a
Sales Maturities Of Investments	278.96M	185.56M	78M	n/a	n/a	n/a
Other Investing Acitivies	8.97M	n/a	-70.49K	-5M	57.00	n/a
Investing Cash Flow	-425.03M	-39.43M	-70.55M	-4.2M	-42K	-125K
Debt Repayment	n/a	24.74M	19.82M	4.92M	5.47M	-188K
Common Stock Repurchased	-13K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-25.85M	-6.2M	-4.01M	-2.21M	-182K	51K
Financial Cash Flow	606.67M	133.54M	101.93M	53.88M	85.29M	-137K
Net Cash Flow	46.97M	1.93M	-36.22M	25.97M	50.44M	-10.55M
Free Cash Flow	-135.65M	-92.24M	-67.66M	-23.71M	-34.91M	-10.41M